News archive

The Next Generation Humane Science Award is available annually to young scientists to acknowledge and encourage researchers who focus on replacing the use of animals in experiments. The 2023 award will be a 1st prize of $5,000 to recognize the outstanding work of one young scientist.

According to a Nature article, officials at the U.S. Food and Drug Administration (FDA) want to allocat a portion of their 2023 budget request to develop a "comprehensive strategy" for alternative methods of testing (NAMs).

A research team led by the Paul Ehrlich Institute (PEI) has discovered that hepatitis B virus particles are transported and released into the environment via small vesicles called exosomes. This may protect the virus particles from attack. This exit route was previously unknown.

Saarland University has launched an online platform on the topic of alternatives for animal experiments. The platform registers the existing alternative methods for animal experiments and names the working groups that have established these methods in Saarland.

Call for Proposals

Friday, 28 October 2022 10:32

Several grants available for the development & application of human-relevant, animal-free methods in research and teaching are available.

Using an organ-on-a-chip system, scientists at the startup Hesperos and the University of Central Florida in Orlando have found out, that skeletal muscle plays an important role in ALS disease independent of motor neurons. The finding could make an important contribution to future therapy for ALS and similar diseases.

A team of researchers at the CUNY Graduate Center of the City University of New York has developed an artificial intelligence model that can predict the impact of a drug in humans more accurately than previous models.

Researchers are working on investigating the effects of nanoparticles on the human body using a specially developed in vitro system.

A team of American-Swedish researchers is convinced that dementia is not caused by increasing deposits of amyloid plaques in the brain but, on the contrary, as a result of a decrease in the amount of soluble amyloid-beta in the brain.

Despite amending the Animal Welfare Act as well as the Animal Welfare Experiments Directive, Germany has still not implemented its legal requirements in conformity with the EU directive of the protection of animals used for scientific purposes. However, the European Union has terminated the infringement proceedings.